Agencies | Governor
Virginia Regulatory Town Hall
Agency
Department of Health Professions
 
Board
Board of Optometry
 
chapter
Regulations of the Virginia Board of Optometry [18 VAC 105 ‑ 20]
 
This action is exempt from the executive branch review process.
Action:
Addition of alpha-adrenergic agonists to TPA formulary
Action 5622 / Stage 9112
Final Stage  
Documents
red ball Final Text 11/17/2020  8:31 am  
pdf Agency Background Document 10/21/2020    
pdf Attorney General Certification 10/30/2020    

Status
Changes to Text No changes have been made to the text since the proposed stage was last published in the Register.
Exempt from APA Yes, this action is exempt from article 2 of the Administrative Process Act. The normal executive branch review process is not required.
Attorney General Review Submitted to OAG: 10/21/2020
 
Review Completed: 10/30/2020
 
Result: Certified
 
Virginia Registrar Submitted on 11/2/2020
 
The Virginia Register of Regulations
 
Publication Date: 11/23/2020    Volume: 37  Issue: 7
Comment Period No comment period held for this exempt action/stage.
Effective Date 12/9/2020
 
Contact Information
Name / Title: Leslie L. Knachel  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233
Email Address: leslie.knachel@dhp.virginia.gov
Telephone: (804)597-4130    FAX: (804)527-4471    TDD: ()-
 
This person is the primary contact for this board.
17
query.....


X
close window 
Action 5622:
Addition of alpha-adrenergic agonists to TPA formulary
 
Stages associated with this regulatory action.
Stage Type Status
Proposed   (9092) Stage complete. No comment period held (exempt from APA).
Final   (9112) Stage complete. Becomes effective on 12/09/2020.
X
close window 
Place On Hold Pending External Action
Enter a reason up to 300 characters. Will be viewable only on the Governor's Pending List.

and return to view the Pending List
A stage can be placed "On Hold" only once. When there are major issues with a stage, please consider asking the agency to withdraw the stage and submit a new stage when it is ready for review.